BLLN
BillionToOne, Inc. - Class A common stock (BLLN)
$94
About BillionToOne, Inc. - Class A common stock (BLLN)
BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.
Details
Daily high
$114.09
Daily low
$106.15
Price at open
$112.22
52 Week High
$150.44
52 Week Low
$61.96
Market cap
5.4B
Dividend yield
-
Volume
993,251
Avg. volume
562,596
P/E ratio
125.65
BillionToOne, Inc. - Class A common stock News
Details
Daily high
$114.09
Daily low
$106.15
Price at open
$112.22
52 Week High
$150.44
52 Week Low
$61.96
Market cap
5.4B
Dividend yield
-
Volume
993,251
Avg. volume
562,596
P/E ratio
125.65